ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

BCI Budget Chief Browning To Retire

January 12, 1979

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

January 25, 2013

Device Maker Threatens Legal Action Against Doctor Who Launched Campaign to End Power Morcellation

September 5, 2014

NCI Cooperative Group, Cancer Center Trials Listed

June 27, 2008

In Brief: Breast Cancer Detection Concept Was For Grants, Not Contracts; Wallens Gets Five Years Probation

November 16, 1984

Komen Foundation Calls For Review Of Action Plan’s Goals

October 24, 1996